I-Mab ADR (IMAB) Social Stream



I-Mab ADR (IMAB): $6.31

0.29 (+4.82%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

I-MAB (IMAB) Price Targets From Analysts

Use the tables below to see what analysts covering I-MAB think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-10 7 $95 $85 $90.3 $6.02 1400%
2022-02-09 6 $95 $85 $90.3 $6.02 1400%
2022-03-30 6 $95 $76 $82.133 $6.02 1264.34%
2022-05-31 7 $95 $35 $72.966 $6.02 1112.06%
2022-08-13 6 $95 $35 $72.966 $6.02 1112.06%
2022-08-30 6 $95 $35 $59.133 $6.02 882.28%
2023-01-26 6 $64.6 $25 $39.1 $6.02 549.5%

The Trend in the Analyst Price Target


IMAB's average price target has moved down $20.03 over the prior 149 days.

IMAB reports an average of 569.28% for its upside potential over the past 50 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-02-09 5 95.0 85 90.300 22.96 293.29%
2022-03-30 6 95.0 76 82.133 18.95 333.42%
2022-03-30 4 95.0 85 90.300 18.95 376.52%
2022-08-18 6 95.0 35 59.133 6.19 855.3%
2022-09-10 6 64.6 25 39.100 5.77 577.64%

IMAB Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.17 5 1 0 0 0 6

The Trend in the Broker Recommendations


Over the past 122 days, IMAB's average broker recommendation rating improved by 0.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • IMAB has a greater upside potential (average analyst target price relative to current price) than 877.33% of all US stocks.
  • In terms of how I-MAB fares relative to stocks in the mid market cap category, note that its variance in analysts' estimates is lower than -291.81% of that group.
  • I-MAB's average analyst price target is greater than 715.31% of Pharmaceutical Products stocks.
  • I-MAB's number of analysts covering the stock is greater than 306.06% of stocks in the mid market cap category.

In the Pharmaceutical Products industry, IGMS, KRTX, and BBIO are the three stocks most similar to I-MAB regarding the price target and analyst recommendation information presented here.

What is the outlook for IMAB? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.666 seconds.